Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02429830 · ClinicalTrials.gov registry record · NA
LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy
A NA study, sponsored by Torax Medical Incorporated.
- Completed
- Registry status
- NA
- Development phase
- 30
- Enrollment target
NCT02429830 is a NA study that has completed, run by Torax Medical Incorporated. The registered enrollment target is 30 participants.
The verdict
NCT02429830, a NA study, has completed, sponsored by Torax Medical Incorporated.
- COMPLETED
- Registry status
- NA
- Development phase
- 30 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate the LINX device in patients who have previously undergone laparoscopic sleeve gastrectomy (LSG) for obesity and have chronic gastroesophageal reflux disease (GERD). The study will monitor safety and changes in reflux symptoms.
Interventions
- DEVICE LINX device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2017-04-05 |
| Est. Completion | 2021-06-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02429830
The ClinicalTrials.gov registry entry for NCT02429830 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Torax Medical Incorporated, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which LINX device is the first listed.
NCT02429830 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02429830 about?
NCT02429830 is a clinical study titled "LINX Reflux Management System in Subjects With GERD Who Have Previously Undergone a Laparoscopic Sleeve Gastrectomy". The purpose of this study is to evaluate the LINX device in patients who have previously undergone laparoscopic sleeve gastrectomy (LSG) for obesity and have chronic gastroesophageal reflux disease (GERD). The study will monitor safety and changes in reflux symptoms.
What is the current status of trial NCT02429830?
This trial is currently completed. It is a NA study. The enrollment target is 30 participants. The study started on 2017-04-05. Estimated completion is 2021-06-08.
What interventions are being tested in trial NCT02429830?
The interventions under investigation include: LINX device (DEVICE).
Who is sponsoring clinical trial NCT02429830?
This trial is sponsored by Torax Medical Incorporated, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.